Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Continued International Investment, Decreased Discrimination Key To Fight Against HIV/AIDS, Says U.N. Secretary-General
U.N. Secretary-General Ban Ki-Moon during a General Assembly meeting Tuesday urged governments not to cut aid for the international fight against HIV/AIDS, the AP/Washington Post reports. Even as Ban "called for "bold action" not only to increase funding but also to break down social barriers to achieve the goal set by world leaders in 2006 of universal access to comprehensive HIV prevention services, treatment, care and support by 2010," he and other speakers at the meeting "reviewing progress and challenges in the battle against AIDS indicated that it will be exceedingly difficult - if not impossible - to reach the goal" (Lederer, AP/Washington Post, 6/16).
generic viagra online
Groundbreaking Artificial Heart Implanted At UMDNJ-Robert Wood Johnson Medical School And Robert Wood Johnson University Hospital
Robert Wood Johnson University Hospital and UMDNJ-Robert Wood Johnson Medical School jointly announce the successful implant of the AbioCor® Total Replacement Heart, the world"s first completely self-contained, fully implantable artificial heart, as well as the first internal artificial organ. The surgery was led by Mark Anderson, MD, associate professor of surgery at UMDNJ-Robert Wood Johnson Medical School and chief of the section of cardiac surgery at both the medical school and Robert Wood Johnson University Hospital, and assisted by Juan Plate, MD, assistant professor of surgery at UMDNJ-Robert Wood Johnson Medical School and an attending surgeon at Robert Wood Johnson University Hospital. Robert Wood Johnson University Hospital is one of only three centers nationwide approved to perform the surgery and the only one in the New York and Philadelphia areas. Dr. Anderson is one of a handful of physicians nationwide trained to perform this procedure. This is the first time the AbioCor has been implanted in a patient since the completion of clinical trials and approval by the Food and Drug Administration.
News of the day
British Public Putting Their Eyesight At Risk
NEARLY two thirds of the British public are neglecting their eyesight, according to the results of a shock survey released today.
Endocrinology

Immunotherapy Against Tau Tangles In Alzheimer's Mouse Models

New insights into how a Phase III Alzheimer"s drug might work were among the advances in potential therapies targeting two abnormal brain proteins - beta amyloid and phosphorylated tau - at ICAD. Scientists also reported on how clinicians view and treat mild cognitive impairment (MCI), a research category used to define the state between normal ageing and Alzheimer"s, that is now being used widely in clinical practice. "Immunotherapy is an important and exciting avenue for dementia research. Unlike the previously reported development of an amyloid vaccine, this new preliminary research has produced antibodies that target the faulty tau protein. Introduction of these antibodies may prevent tangles from forming in nerve cells in the brain. Early results have shown some promise but this is preliminary research and some technical challenges need to be overcome before this study can be translated into drug treatments for people with dementia." Professor Clive Ballard Director of Research Alzheimer"s Society The International Conference on Alzheimer"s Disease is held in Vienna from 11 - 16 July. Please visit ICAD for further information. http://www.alzheimers.org.uk Alzheimer"s Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009